| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Ginkgo Bioworks Holdings, Inc. (DNA) has 2 insiders with recent SEC Form 4 filings, including 2 buys and 9 sells. DNA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 24.3K | $216.1K | - | |
| Other | 7.5K | $66.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 16, 2024 | Dekkers Marijn E80 | Director | Sell | 265,000 | $0.83 | $220,029.50 | -4.6% | -71.2% | -76.4% | |
| May 15, 2024 | Sankar Shyam | Director | Buy | 625,000 | $0.82 | $514,750.00 | +36.1% | -66.5% | -77.1% | |
| May 14, 2024 | Dekkers Marijn E80 | Director | Sell | 1,727,056 | $0.93 | $1,606,162.08 | -86.0% | -69.6% | -77.3% | |
| May 14, 2024 | Sloan Harry | Director | Buy | 297,619 | $0.91 | $271,815.43 | +70.7% | -69.6% | -77.3% | |
| May 2, 2024 | Coen Steven P.70 | See Remarks | Sale+OE | 131,928 | $0.85 | $111,479.16 | -44.8% | -55.9% | -79.6% | |
| May 2, 2024 | Dmytruk Mark E.78 | See Remarks | Sale+OE | 47,806 | $0.85 | $40,396.07 | -4.9% | -55.9% | -79.6% | |
| Apr 2, 2024 | Dmytruk Mark E.78 | See Remarks | Sale+OE | 51,169 | $1.05 | $53,727.45 | -5.6% | -69.2% | -85.8% | |
| Mar 4, 2024 | Dmytruk Mark E.78 | See Remarks | Sale+OE | 38,826 | $1.26 | $48,765.46 | -4.6% | -57.0% | -83.9% | |
| Feb 2, 2024 | Dmytruk Mark E.78 | See Remarks | Sale+OE | 39,569 | $1.21 | $47,799.35 | -4.9% | -32.2% | -73.7% | |
| Jan 4, 2024 | Kelly Jason R86 | See Remarks | Sell | 200,000 | $1.55 | $309,900.00 | -2.5% | -30.1% | -81.5% |